Impact Omics SRL
1.0 FTEThe score of Impact Omics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +103 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Impact Omics's annual accounts
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Net result | −138,281 € | |||
| Equity | −102,374 € | |||
| Cash | 22,643 € | |||
| EBITDA | 28,485 € | |||
| Total assets | 102,349 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Jul 2026
- Year ended 31 Dec 2024filed on 17 Sep 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
Impact Omics's financial analysis
- Solvency-100.0%sector median: 75.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Impact Omics
Impact Omics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0779.683.030
- VAT number
- BE0779683030
- Peppol
- Registered · 0208:0779683030 · as of 03 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jan 2022
- Registered office
- 3840 Tongeren-Borgloon
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 13 Jul 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Impact Omics (SRL) has been based in Tongeren-Borgloon since 2022, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net loss of 138,281 € and equity of −102,374 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -100.0%, below the median of its sector (75.0%).
Companies similar to Impact Omics
Companies in the same business, of comparable size and area, outside its group.
- AnaLIStics Research and experimental development on natural sciences and engineering Kontich · balance sheet 208,698 €
- Dr. Van Haeringen Polygen Research and experimental development on natural sciences and engineering Malle · balance sheet 63,230 €
- Biocli Consult Research and experimental development on natural sciences and engineering Jurbise · balance sheet 302,775 €
- Epsilon-Biotech Research and experimental development on natural sciences and engineering Zonhoven · balance sheet 244,785 €
- SciLife Consulting Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 198,474 €
- GC Laboratory Europe Technical testing and analysis Leuven · balance sheet 406,216 €
- Radiologie DRS.VAN Meerbeeck Other education n.e.c. Bornem · balance sheet 843,721 €
- Spectralys Biotech Research and experimental development on natural sciences and engineering Charleroi · balance sheet 444,695 €
Frequently asked questions about Impact Omics
What is the revenue of Impact Omics?
Impact Omics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Impact Omics?
In Belgium, the VAT number is the company number prefixed with BE: BE0779683030 for Impact Omics, if the company is VAT-registered. Its company number (CBE) is 0779.683.030.
Where is the registered office of Impact Omics?
According to the CBE register, the registered office of Impact Omics is in 3840 Tongeren-Borgloon.
What is the equity of Impact Omics?
At the close of the 2025 financial year, the equity of Impact Omics amounts to -102,374 €, a solvency of -100.0% of total assets.
How many people work at Impact Omics?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Impact Omics?
The register lists 2 active mandates at Impact Omics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Impact Omics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →